AbbVie currently has more than 100 active partnerships with other companies who share our commitment to oncology to strengthen our pipeline, and with research and academic institutions, to deepen our knowledge of core areas of biology.

In the UK we engage in innovative partnering and collaboration opportunities that allow us to share novel science and technology and enhance our ability to innovate for patients.

Abbvie was a founding partner in Genomics England’s Discovery Forum which brought together academia, Government, the NHS and industry, to increase collective understanding of the genetic basis of cancer.

And with the demands cancer places on the NHS, our expanding AbbVie UK expert oncology team is working with regulatory and NHS bodies to ensure as rapid access as possible to our treatments. At the same time, generating evidence of the value these advancements bring to the UK healthcare system.